# Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

> **NCT00288392** · PHASE2 · COMPLETED · sponsor: **Biotec Pharmacon ASA** · enrollment: 60 (—)

## Conditions studied

- Foot Ulcer

## Interventions

- **DRUG:** Soluble beta-1,3/1,6-glucan

## Key facts

- **NCT ID:** NCT00288392
- **Lead sponsor:** Biotec Pharmacon ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288392, "Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00288392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*